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1. INTRODUCTION {#irv12508-sec-0005}
===============

Acute lower respiratory infections (ALRI) include conditions such as bronchiolitis, pneumonia and influenza. The true burden of disease is difficult to calculate with estimates heavily influenced by identification methods. Globally, an estimated 10 per 1000 children aged less than 5 years were hospitalized for ALRI in 2010 in the developed world.[1](#irv12508-bib-0001){ref-type="ref"} Using linked administrative data, we estimated that in Western Australia (WA) the true rate was significantly higher; approximately 45 per 1000 children were hospitalized for ALRI before their second birthday, with a much higher burden among Aboriginal and Torres Strait Islander children (hereafter referred to as Aboriginal).[2](#irv12508-bib-0002){ref-type="ref"}

Viruses associated with ALRI include influenza viruses, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Current vaccines targeting ALRI viral pathogens are limited to influenza; however, multiple RSV vaccine candidates are in clinical trials.[3](#irv12508-bib-0003){ref-type="ref"} Accurate pathogen‐specific estimates are paramount before planning or evaluating prevention programmes.

At present, most retrospective studies using hospital admission data to investigate the aetiology of ALRI begin by selecting children with an International Classification of Disease (ICD) discharge code for ALRI. ICD codes alone are insufficient to provide accurate estimates of the true burden of respiratory pathogens because they are poorly sensitive,[4](#irv12508-bib-0004){ref-type="ref"} with limited use of pathogen‐specific codes. Furthermore, data are often from selected hospitals and may not be representative of the wider population. One method for more accurate calculations of the pathogen‐specific burden for a whole population is record linkage.

Record linkage combines data from multiple sources relating to the same person.[5](#irv12508-bib-0005){ref-type="ref"} Access to large, population‐level data sets at relatively low cost is one advantage of record linkage over prospective studies.[6](#irv12508-bib-0006){ref-type="ref"} We have shown that record linkage is a feasible and valid method for describing the pathogen‐specific aetiology of ALRI.[7](#irv12508-bib-0007){ref-type="ref"}, [8](#irv12508-bib-0008){ref-type="ref"} It is also useful for identifying conditions and populations where current databases underestimate the burden of disease.

We first sought to more accurately describe the pathogen‐specific burden of respiratory viruses (specifically by age‐specific rates and clinical diagnoses) identified in a cohort of WA‐born children hospitalized between 2000 and 2012. As significant portions of hospitalized children are not tested for respiratory viruses, their viral burden is probably underestimated. Therefore, we also aimed to characterize those who were not tested so that statistical modelling could be used to assign viruses to those who were not tested, based on demographic and admission factors.

2. PATIENTS AND METHODS {#irv12508-sec-0006}
=======================

2.1. Setting and data sources {#irv12508-sec-0007}
-----------------------------

WA covers 2.5 million square kilometres with a population of approximately 2.5 million people at June 2015.[9](#irv12508-bib-0009){ref-type="ref"} Through the WA Data Linkage Branch, we identified a birth cohort of children born in WA between 1996 and 2012 from the Midwives Notifications System, Birth and Death Registries. We then extracted data relating to these children from the Hospital Morbidity Data Collection, PathWest Laboratory Medicine Database (PathWest) and the Western Australian Notifiable Infectious Diseases Database (WANIDD). All live births were included in the following analyses.

2.2. Hospital data {#irv12508-sec-0008}
------------------

As PathWest data were only available from 2000, we restricted hospital records to those with an admission date between January 2000 and December 2012. Only hospital records with an admission and discharge date during the study period were included (hereafter referred to as hospital admissions). Admissions on or after the date of death were considered post‐mortem admissions and excluded.

Clinical diagnosis was classified using a hierarchy of ALRI, upper respiratory tract infections (URTI), or other, with priority given to ALRI. Admissions were classified as ALRI if they had a principal or codiagnosis ICD‐10‐AM (ICD 10th revision, Australian Modification) code for pneumonia, bronchiolitis, influenza, unspecified ALRI, bronchitis or whooping cough (codes listed in Table [S1](#irv12508-sup-0001){ref-type="supplementary-material"}).[10](#irv12508-bib-0010){ref-type="ref"} Admissions with a principal or codiagnosis of URTI, such as otitis media and sinusitis, were classified as URTI (Table [S1](#irv12508-sup-0001){ref-type="supplementary-material"}).[11](#irv12508-bib-0011){ref-type="ref"} All other admissions were classified as "other" and further subdivided based on principal diagnosis codes (Table [S1](#irv12508-sup-0001){ref-type="supplementary-material"}).

Interhospital transfers were defined as multiple adjacent records of the same person where either (i) the admission date was identical to the discharge date of the prior record; or (ii) the admission date occurred before the discharge date of the prior record; or (iii) both admission and discharge dates fell within the time span of the prior record. These records were collapsed and considered a single admission. A child was coded as admitted to an intensive care unit (ICU) if they spent at least 1 day in ICU as recorded on the Hospital Morbidity Data Collection. Mechanical ventilation was defined as receipt of at least an hour of continuous ventilatory support or having procedure codes (classified using the 7th edition of the Australian Classification of Health Interventions) for airway management, invasive or non‐invasive ventilatory support (Table [S1](#irv12508-sup-0001){ref-type="supplementary-material"}).

2.3. Laboratory data {#irv12508-sec-0009}
--------------------

PathWest is the sole public pathology provider in WA and services all but three hospitals admitting paediatric patients in the state. It also processes referred samples from private pathology laboratories in WA. Further details on PathWest are provided elsewhere.[7](#irv12508-bib-0007){ref-type="ref"} WANIDD is managed by the WA Department of Health and collects information on all notifiable infectious diseases in WA. We combined PathWest and WANIDD data on respiratory specimens collected from the birth cohort between January 2000 and December 2012.

We included laboratory data from nasal/nasopharyngeal (NP), throat, tracheal, bronchial, sputum, lung, pleural fluid, blood or serum specimens. Nasal/NP specimens included combined nose and throat, nasopharyngeal, per‐ and postnasal swabs and aspirates. Specimens where respiratory virus testing was requested and used one or more detection methods (including antigen detection \[eg, immunofluorescent antibodies\], polymerase chain reaction \[PCR\], viral culture and serology) were included. We focussed on respiratory viruses as parallel data on testing for bacterial pathogens were incomplete. Moreover, the sensitivity and specificity of current microbiology diagnostics for bacterial ALRI are relatively poor.

Respiratory viruses routinely tested on respiratory specimens included RSV, influenza A and B, human adenovirus and parainfluenza types 1‐3. Testing for hMPV was available from 2003 and routinely tested from 2008. Testing for other respiratory viruses, like human picornaviruses, was performed only on request. Picornaviruses were detected by PCR and viral culture but were not routinely speciated into rhinovirus or enterovirus. A specimen was deemed to test positive if one or more of adenovirus, influenza virus (any type), parainfluenza virus (any type), hMPV, picornavirus (unspeciated), rhinovirus or RSV were detected by antigen detection, PCR, culture or serology. Admissions where both picornavirus and rhinovirus were detected were coded as rhinovirus, whereas if only an unspecified picornavirus was identified, it was coded as a picornavirus admission.

Laboratory records were merged with a hospital record if respiratory specimens were collected 48 hours before or after the admission date. If the same person had multiple admissions for different reasons within 48 hours, laboratory records were linked to the ALRI admission. If the same person had multiple admissions for the same reason within 48 hours, laboratory records were linked to the admission closest to the date of specimen collection.

2.4. Statistical analysis {#irv12508-sec-0010}
-------------------------

After merging hospital and laboratory records, we compared the clinical characteristics of admissions classified as ALRI, URTI and other. We then identified those with at least one virus detected and calculated the frequency and incidence of each virus by diagnosis, age and Aboriginal status. Incidence rates were calculated using person‐time‐at‐risk as the denominator, derived from dates of birth, death and end of the study (31 December 2012). Aboriginal children were identified using a derived variable provided by the WA Data Linkage Branch.[12](#irv12508-bib-0012){ref-type="ref"}

We used logistic regression to identify admission‐specific factors associated with failing to have a virology test (outcome variable), clustering by person to allow for multiple admissions of the same person. Variables were selected based on clinical plausibility and/or a p‐value of less than 0.05 compared to the base model. These were included in the multivariable model to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CI). All variables except admission year were included as categorical variables. Admission year was included as a continuous variable. All admissions were included in the adjusted models. The same model was used to calculate aOR of failing to test for a respiratory virus among those who received an ALRI diagnosis.

Data cleaning and descriptive analyses were performed in IBM SPSS (version 23). Regression models were developed in Stata Corp. STATA (version 14.1). Chi‐squared test for proportions, incidence rate ratios and exact 95% CI were calculated using EpiBasic (version 3).[13](#irv12508-bib-0013){ref-type="ref"} Ethical approvals were obtained from the WA Department of Health Human Research Ethics Committee, the WA Aboriginal Health Ethics Committee and the University of Western Australia Human Research Ethics Committee.

3. RESULTS {#irv12508-sec-0011}
==========

Of 469 589 children born between January 1996 and December 2012, 31 348 (6.7%) were Aboriginal and 240 237 (51.2%) were boys. Singleton births accounted for 97.0% of the cohort and 2428 children (0.5%) had died by 2012, resulting in 3 753 975.3 person‐years in total. Of those who died, ALRI was listed as the cause of death for 76 children (3.1%). Between January 2000 and December 2012, 45.4% (n = 213 365) of the cohort were hospitalized at least once, contributing to 485 054 admissions (Figure [1](#irv12508-fig-0001){ref-type="fig"}). Of these, 62 were considered post‐mortem admissions and excluded. Of the remaining admissions, 9.0% linked to a laboratory record for respiratory virus testing (Figure [1](#irv12508-fig-0001){ref-type="fig"}).

![Flow chart of testing for respiratory viruses and diagnosis. Total number of children admitted in each category may not equal the total number of children hospitalized as a child may be hospitalized more than once](IRV-11-502-g001){#irv12508-fig-0001}

3.1. Comparing disease burden using hospital and laboratory data {#irv12508-sec-0012}
----------------------------------------------------------------

We observed that 9.4% (n = 45 691) of all admissions had an ALRI diagnosis code (Figure [1](#irv12508-fig-0001){ref-type="fig"}), with bronchiolitis (n = 20 075, 43.9%) and pneumonia (n = 13 528, 29.6%) the most common diagnoses. However, only 45.7% (20 874/45 691) of admissions with an ALRI diagnosis linked to a laboratory record. Similarly, 17.6% (n = 85 141) of all admissions had a URTI diagnosis, but only 7.1% (6019/85 141) linked to a laboratory record (Figure [1](#irv12508-fig-0001){ref-type="fig"}).

Of all laboratory‐confirmed admissions, 47.8% had an ALRI diagnosis (n = 20 874; Figure [1](#irv12508-fig-0001){ref-type="fig"}). Over 70% of laboratory‐confirmed admissions with an ALRI diagnosis concerned children aged less than 2 years old at admission (Table [S2](#irv12508-sup-0002){ref-type="supplementary-material"}). The majority of these children were diagnosed with bronchiolitis (n = 11 413) or pneumonia (n = 4484). Of the laboratory‐confirmed admissions with an URTI diagnosis, acute upper respiratory infection (n = 5558) was the most common diagnosis.

We noted that 38.4% of laboratory‐confirmed admissions did not have an ALRI or URTI diagnosis (Figure [1](#irv12508-fig-0001){ref-type="fig"}). These were commonly coded as viral infection of an unspecified site (n = 3338, 19.9%); other infections (n = 1786, 10.7%); asthma (n = 1595, 9.5%); or breathing abnormalities (n = 1228, 7.3%; Table [1](#irv12508-tbl-0001){ref-type="table-wrap"}). Approximately 12.5% of these admissions related to children aged 5 years or more at admission and 12.3% of these admissions included a stay in ICU (Table [S2](#irv12508-sup-0002){ref-type="supplementary-material"}).

###### 

Frequency and incidence rates of respiratory viruses per 100 000 child‐y among those who were tested

  Description                           Tested   Any virus   RSV    Parainfluenza   Influenza   Rhinovirus   Adenovirus   Unspeciated picornavirus[a](#irv12508-note-0001){ref-type="fn"}   hMPV                                                    
  ------------------------------------- -------- ----------- ------ --------------- ----------- ------------ ------------ ----------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------
  ALRI diagnoses                        20 874   12 192      58.4   7590            213.7       1201         33.8         1795                                                              50.5   579    16.3   691    19.5   165    4.6    751    21.1
  Acute bronchiolitis                   11 413   7495        65.7   5959            167.8       540          15.2         102                                                               2.9    320    9.0    408    11.5   62     1.7    435    12.2
  Pneumonia                             4484     1966        43.8   1067            30.0        235          6.6          265                                                               7.5    146    4.1    153    4.3    41     1.2    190    5.4
  Unspecified ALRI                      2864     1036        36.2   474             13.3        209          5.9          61                                                                1.7    87     2.4    98     2.8    53     1.5    108    3.0
  Influenza due to identified virus     1611     1546        96.0   21              0.6         187          5.3          1357                                                              38.2   \<5    0.1    17     0.5    \<5    0.1    16     0.5
  Whooping cough                        322      64          19.9   24              0.7         13           0.4          5                                                                 0.1    12     0.3    6      0.2    5      0.1    \<5    0.0
  Bronchitis                            180      85          47.2   45              1.3         17           0.5          5                                                                 0.1    12     0.3    9      0.3    \<5    0.0    \<5    0.0
  URTI                                  6019     1904        31.6   580             16.3        339          9.5          117                                                               3.3    304    8.6    369    10.4   141    4.0    125    3.5
  Other diagnoses                       16 734   3651        21.8   598             16.8        680          19.1         248                                                               7.0    681    19.2   441    12.4   946    26.6   179    5.0
  Viral infection of unspecified site   3338     917         27.5   112             3.2         212          6.0          89                                                                2.5    115    3.2    187    5.3    193    5.4    42     1.2
  Other infections                      1786     417         23.3   37              1.0         30           0.8          20                                                                0.6    29     0.8    49     1.4    257    7.2    9      0.3
  Asthma                                1595     512         32.1   138             3.9         33           0.9          10                                                                0.3    222    6.3    14     0.4    83     2.3    23     0.6
  Cystic fibrosis                       655      19          2.9    \<5             0.1         9            0.3          \<5                                                               0.0    \<5    0.1    \<5    0.1    0      0.0    0      0.0
  Other respiratory                     1064     406         38.2   79              2.2         235          6.6          25                                                                0.7    28     0.8    20     0.6    8      0.2    21     0.6
  Breathing abnormalities               1228     272         22.1   87              2.4         25           0.7          \<5                                                               0.1    30     0.8    32     0.9    87     2.4    23     0.6
  Fever                                 677      118         17.4   19              0.5         15           0.4          16                                                                0.5    20     0.6    22     0.6    29     0.8    \<5    0.0
  Convulsions                           459      57          12.4   11              0.3         11           0.3          10                                                                0.3    5      0.1    13     0.4    7      0.2    \<5    0.1
  Abnormal clinical signs               657      65          9.9    11              0.3         10           0.3          9                                                                 0.3    15     0.4    11     0.3    11     0.3    \<5    0.1
  Other                                 5275     868         16.5   100             2.8         100          2.8          64                                                                1.8    214    6.0    91     2.6    271    7.6    55     1.5
  Total                                 43 627   17 747      40.7   8769            246.9       2220         62.5         2160                                                              60.8   1564   44.0   1501   42.3   1252   35.3   1055   29.7

Unspeciated picornavirus includes some detections of rhinovirus but these could not be distinguished from other types of picornaviruses (eg, enterovirus).

ALRI, acute lower respiratory infections, URTI, upper respiratory tract infection, RSV, respiratory syncytial virus, hMPV, human metapneumovirus. Rate presented is per 100 000 child‐y.

John Wiley & Sons, Ltd

3.2. Pathogen‐specific burden of respiratory viruses {#irv12508-sec-0013}
----------------------------------------------------

Overall, 40.7% (n = 17 747) of laboratory‐confirmed admissions had at least one respiratory virus detected. Virus detection was highest among those diagnosed with ALRI (n = 12 192, 58.4%) and among children aged 6‐23 months at admission (n = 7087, 39.9%). Approximately 20.6% (n = 3651) of laboratory‐confirmed admissions with at least one virus detected did not have an ALRI or URTI diagnosis (Table [1](#irv12508-tbl-0001){ref-type="table-wrap"}). RSV was the most commonly detected virus, with an incidence rate that was four times higher (95% CI=3.8‐4.1) than the next most common virus (Table [1](#irv12508-tbl-0001){ref-type="table-wrap"}). RSV incidence rates were highest among children under 6 months of age (Figure [2](#irv12508-fig-0002){ref-type="fig"}A) and among those diagnosed with bronchiolitis (Table [1](#irv12508-tbl-0001){ref-type="table-wrap"}).

![Incidence rates for (A) RSV and (B) other viruses among children aged \<5 years. Note the differences in scale between A and B](IRV-11-502-g002){#irv12508-fig-0002}

Unspeciated picornavirus, RSV, parainfluenza and rhinovirus had similar incidence rates among children with other diagnoses (Table [1](#irv12508-tbl-0001){ref-type="table-wrap"}). Rates of unspeciated picornavirus were highest among infants aged less than 1 month (Figure [2](#irv12508-fig-0002){ref-type="fig"}B). On the other hand, rates of parainfluenza and influenza virus peaked in children aged 1‐5 months. Among all laboratory‐confirmed admissions with parainfluenza detected, parainfluenza type three was the most common (n = 1548, 69.7%), followed by parainfluenza type one (n = 487, 21.9%). Influenza A (n = 1683, 76.7%), predominantly A/H1N1 (n = 327), was the most common type among those with influenza.

Viruses were detected more frequently in Aboriginal (n = 2931, 45.2% positive) compared to non‐Aboriginal children (n = 14 816, 39.9% positive; p \< .001). However, these differences disappeared when further segregated by diagnoses. Virus distribution did not differ between Aboriginal and non‐Aboriginal children, although rates were at least twice as high in Aboriginal children for all viruses except for unspeciated picornavirus, which was 1.7 times higher (95% CI=1.4‐2.0) compared to non‐Aboriginal children. Two or more viruses were seen in approximately 4.1% (n = 723) of admissions testing positive for at least one virus, most commonly with RSV‐adenovirus (n = 206) and RSV‐parainfluenza pairs (n = 114).

3.3. Exploring under‐ascertainment of respiratory viruses {#irv12508-sec-0014}
---------------------------------------------------------

Univariable analyses suggested that age at admission, diagnosis, length of stay, hospital type and mechanical ventilation were strongly associated with failure to test for respiratory viruses (Table [2](#irv12508-tbl-0002){ref-type="table-wrap"}). These variables remained significant after adjusting for all other variables in the multivariable model.

###### 

Logistic regression of admission‐specific factors associated with failing to test for respiratory viruses

  Description                                             Total     Tested   Univariable   Multivariable           
  ------------------------------------------------------- --------- -------- ------------- --------------- ------- ---------------
  Admission year[a](#irv12508-note-0003){ref-type="fn"}                      1.03          (1.02‐1.03)     0.95    (0.94‐0.95)
  Age at admission                                                                                                 
  \<1 mo                                                  23 656    3271     Ref                                   
  1‐5 mo                                                  40 216    11 262   0.41          (0.39‐0.43)     0.72    (0.68‐0.76)
  6‐23 mo                                                 112 146   16 787   0.91          (0.87‐0.95)     1.11    (1.06‐1.17)
  2‐4 y                                                   146 021   8106     2.73          (2.60‐2.87)     2.32    (2.20‐2.45)
  5‐9 y                                                   113 179   3240     5.44          (5.08‐5.84)     4.31    (4.05‐4.58)
  10‐16 y                                                 49 774    961      8.15          (7.37‐9.01)     7.87    (7.25‐8.55)
  Season of admission                                                                                              
  Summer (December--February)                             104 327   6363     2.24          (2.17‐2.31)     1.51    (1.45‐1.56)
  Autumn (March--May)                                     114 864   7812     1.99          (1.94‐2.05)     1.44    (1.39‐1.49)
  Winter (June--August)                                   133 383   16 940   Ref                                   
  Spring (September--November)                            132 418   12 512   1.39          (1.36‐1.43)     1.06    (1.03‐1.10)
  Diagnosis                                                                                                        
  ALRI                                                    45 691    20 874   Ref                                   
  URTI                                                    85 141    6019     11.06         (10.67‐11.46)   4.71    (4.54‐4.90)
  Other                                                   354 160   16 734   16.96         (16.49‐17.45)   14.68   (14.21‐15.15)
  ICU admission                                                                                                    
  No                                                      465 854   40 100   4.10          (3.92‐4.29)     1.12    (1.06‐1.20)
  Yes                                                     19 138    3527     Ref                                   
  Length of stay                                                                                                   
  1 d                                                     204 348   2971     Ref                                   
  2 d                                                     140 618   10 095   0.19          (0.18‐0.20)     0.29    (0.28‐0.30)
  3 or more days                                          140 026   30 561   0.05          (0.05‐0.06)     0.11    (0.11‐0.12)
  Inter‐hospital transfers                                                                                         
  No                                                      475 260   42 358   Ref                                   
  Yes                                                     9732      1269     0.65          (0.61‐0.69)     1.27    (1.18‐1.37)
  Hospital type                                                                                                    
  Tertiary                                                214 629   30 030   Ref                                   
  Metropolitan (public)                                   44 930    4197     1.58          (1.52‐1.64)     3.32    (3.18‐3.47)
  Rural (public and private)                              102 880   5739     2.75          (2.65‐2.86)     9.14    (8.80‐9.49)
  Metropolitan (private)                                  122 553   3661     5.28          (5.07‐5.50)     5.63    (5.40‐5.87)
  Mechanical ventilation                                                                                           
  No                                                      482 140   42 279   9.32          (8.60‐10.11)    1.88    (1.70‐2.09)
  Yes                                                     2852      1348     Ref                                   

Included as a continuous variable.

ALRI, acute lower respiratory infections; URTI, upper respiratory infections; OR, odds ratio; aOR, adjusted odds ratio; ICU, intensive care unit. Multivariable model adjusted for all other variables listed.

John Wiley & Sons, Ltd

Children over 5 years of age and those without an ALRI diagnosis had at least fourfold greater odds of not being tested (Table [2](#irv12508-tbl-0002){ref-type="table-wrap"}). Furthermore, admissions to non‐tertiary hospitals had at least threefold odds of not being tested than admissions to tertiary hospitals. When restricted to admissions with an ALRI diagnosis, results were similar for all variables except ICU admission and interhospital transfers (Table [S3](#irv12508-sup-0003){ref-type="supplementary-material"}). Children admitted to regular wards with an ALRI diagnosis had 0.71 times the odds of failing to test for respiratory viruses compared to those admitted to ICU (Table [S3](#irv12508-sup-0003){ref-type="supplementary-material"}). Likewise, admissions following interhospital transfers had lower odds of not receiving a test than those who were transferred (Table [S3](#irv12508-sup-0003){ref-type="supplementary-material"}).

4. DISCUSSION {#irv12508-sec-0015}
=============

As ICD codes alone can underestimate the burden of respiratory viruses, we used linked laboratory and hospital data to determine more accurate estimates of the virus‐specific burden of ALRI among hospitalized children. We determined that the overall incidence rate of RSV was 247 per 100 000 child‐years, with a similar rate among those diagnosed with ALRI. Incidence rates for other respiratory viruses ranged from 30 to 63 per 100 000 child‐years. A third of all laboratory‐confirmed admissions were not diagnosed with ALRI or URTI. Children over 5 years of age, not receiving a diagnosis of ALRI and admission to a non‐tertiary hospital, were strongly associated with failing to test for respiratory viruses.

RSV, parainfluenza and influenza were the most commonly detected viruses, with the greatest burden among children under 6 months old. Much of previous preventative effort towards viral ALRI has focused on influenza. More recently, investigations have turned towards RSV and parainfluenza, with 60 RSV vaccine candidates currently in clinical or preclinical development[3](#irv12508-bib-0003){ref-type="ref"} and a dozen parainfluenza vaccine candidates.[14](#irv12508-bib-0014){ref-type="ref"}, [15](#irv12508-bib-0015){ref-type="ref"} Given the relative greater burden of RSV and parainfluenza, increased efforts are needed to address these two pathogens. Prevention of all three viruses would greatly reduce the burden of ALRI and potentially 20%‐30% of other hospitalizations as well.

Approximately 38% of all laboratory‐confirmed admissions were not coded as ALRI or URTI, with 22% of these admissions testing positive for at least one respiratory virus. These do not appear to be solely attributable to asymptomatic virus identification as many of these viruses were infrequently detected in asymptomatic children.[16](#irv12508-bib-0016){ref-type="ref"} Moreover, these laboratory‐confirmed admissions were mostly unspecified diagnosis codes (eg, viral infections of unspecified site) or non‐specific clinical symptoms (eg, breathing abnormalities). This highlights the limitations of using ICD codes alone when calculating disease estimates, as documented elsewhere.[4](#irv12508-bib-0004){ref-type="ref"}, [17](#irv12508-bib-0017){ref-type="ref"}, [18](#irv12508-bib-0018){ref-type="ref"} Previous studies also support the notion that coding algorithms, particularly for less well‐defined diseases, are needed for accurate disease estimates.[19](#irv12508-bib-0019){ref-type="ref"} These are crucial to policy development and are often used as baseline data when evaluating the impact of said policies. Our findings further highlight the need to look beyond ICD codes when estimating infectious disease burden and the impact of vaccination programs.

While there were many laboratory‐confirmed admissions without a respiratory code, over half of all ALRI admissions were not tested for respiratory viruses, implying that the burden of specific viruses is still underestimated. Without the capacity to directly influence testing patterns and because it is economically unfeasible to impose universal testing, one possibility to address this issue is by statistical modelling. By characterizing those testing positive for particular viruses, we could extrapolate virus "detection" to those with similar characteristics but not tested. This method was used on similar data in England,[20](#irv12508-bib-0020){ref-type="ref"} and a future study using these data is planned.

We noted that admissions to private metropolitan hospitals had five times greater odds of failing to test compared to tertiary hospitals. As a limited number of private hospitals do not routinely use PathWest laboratories, it is difficult to differentiate testing practices from specimen referral pathways. Despite this, the frequency of virus detection in private metropolitan hospitals in this data set was comparable to tertiary hospitals, as was the distribution of viruses (data not shown). Inclusion of laboratory data from private pathology providers would thus further enhance our disease estimates.

Previous work validating linked laboratory data in WA suggested that approximately 75% of ALRI‐related admissions should have an associated laboratory record for respiratory pathogen testing.[8](#irv12508-bib-0008){ref-type="ref"} Notwithstanding the exclusion of bacterial pathogens and commonly associated tests (eg, blood culture), the proportion of laboratory‐confirmed admissions with an ALRI diagnosis is still suboptimal despite improving our extraction protocols. While linkage errors (eg, misidentification of individuals across data sets) may have partially contributed to this issue, it is likely to be minimal as approximately 95% of PathWest records were linked successfully (personal communication, WA Data Linkage Branch).

We were unable to investigate the role of comorbidities (eg, immunosuppression) and antiviral use on testing practices and the frequency of virus detection. We also could not examine the emerging role of rhinovirus in severe respiratory infections[21](#irv12508-bib-0021){ref-type="ref"} as picornaviruses were not routinely speciated. While we focussed on respiratory viruses, competition and interactions with bacterial pathogens are likely to influence incidence rates of individual viruses investigated here. Inclusion of data on bacterial pathogens is the next step in assessing the burden of all respiratory pathogens.

5. CONCLUSION {#irv12508-sec-0016}
=============

Despite these limitations, this is one of the few studies, to our knowledge, to quantify the population‐level burden of respiratory viruses in children, irrespective of diagnosis. It is also the first to use individual, rather than aggregated, person‐time‐at‐risk data to more accurately estimate the rate of respiratory virus infection. This has enabled reporting of pathogen‐specific incidence rates of these viruses, the majority of which are not notifiable. Access to data on all admissions for a whole population, in addition to both positive and negative test results, is a major strength of this study. Using these data, we have shown that respiratory viruses are pervasive and their prevention could reduce the burden of respiratory and non‐respiratory hospitalizations. These data provide a framework for further, in‐depth studies to enhance current and future preventative strategies. We plan to use these data to investigate temporal trends and risk factors for specific viruses and their combinations in the context of changes in testing patterns.
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